24 Feb 2026 16:03 CET

Reference is made to the resolution by the extraordinary general meeting of
Aqua Bio Technology ASA (the "Company") on 16 February 2026, regarding a share
capital increase to facilitate a reverse share split. The share capital
increase consists of 33 new shares, at a subscription price of NOK 0.25 per
share and at a par value of NOK 0.10 per share, corresponding to a total
increase in the share capital of NOK 3.30.

The share capital increase mentioned above has now been registered with the
Norwegian Register of Business Enterprises. The new share capital of the
Company is NOK 16,139,675 divided by 161,396,750 shares, each with a par value
of NOK 0.10.

Contacts
Kristian Flaten
CEO & CFO
Aqua Bio Technology ASA

Phone: +47 9509 2322
Email: kf@aquabiotech.no

About Us
Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in
skincare and nonfood. The group has distribution towards B2C and B2B, and
offers freight, customs, and logistics services. The group also develops
sustainable biotechnology for use in skincare products. Aqua Bio Technology is
listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR Article 17. The information was submitted for publication,
through the agency of the contact persons set out above, at 2026-02-24 16:03
CET.


666604_Aqua Bio Technology ASA- Share capital increase registered.pdf

Source

Aqua Bio Technology ASA

Provider

Oslo Børs Newspoint

Company Name

AQUA BIO TECHNOLOGY

ISIN

NO0010307135, NO0013735894

Symbol

ABTEC

Market

Euronext Expand